BetterLife Pharma Inc. Files Routine 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Apr 11, 2024 · CIK: 1464165
| Field | Detail |
|---|---|
| Company | Betterlife Pharma INC. (BETRF) |
| Form Type | 6-K |
| Filed Date | Apr 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
BetterLife Pharma (BETRF) filed a standard 6-K, nothing major but shows they're still reporting.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K on April 11, 2024, reporting for the month of April 2024. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is based in Vancouver, BC, and operates in the Pharmaceutical Preparations sector. This filing is a routine report for foreign private issuers.
Why It Matters
This filing indicates ongoing compliance and reporting by BetterLife Pharma Inc. as a foreign private issuer, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine filing and does not contain new material information that would inherently increase risk.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Filer of the report
- Pivot Pharmaceuticals Inc. (company) — Former company name
- Neurokine Pharmaceuticals Inc. (company) — Former company name
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, typically to provide information that the issuer makes or is required to make public in its home country.
When was BetterLife Pharma Inc. previously known by other names?
BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. (name change date: 20150417) and Neurokine Pharmaceuticals Inc. (name change date: 20090514).
What is BetterLife Pharma Inc.'s Standard Industrial Classification code?
BetterLife Pharma Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Where is BetterLife Pharma Inc. located?
BetterLife Pharma Inc.'s principal executive office is located at 1275 West 6th Avenue, Vancouver, BC V6H 1A6.
Does BetterLife Pharma Inc. file annual reports under Form 20-F or 40-F?
The filing indicates that BetterLife Pharma Inc. files annual reports under cover of Form 20-F.
Filing Stats: 343 words · 1 min read · ~1 pages · Grade level 14.8 · Accepted 2024-04-11 12:00:12
Filing Documents
- betrf_6k.htm (6-K) — 10KB
- betrf_ex991.htm (EX-99.1) — 21KB
- betrf_6kimg1.jpg (GRAPHIC) — 4KB
- 0001477932-24-001982.txt ( ) — 37KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 , the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BETTERLIFE PHARMA INC. Date: April 11, 2024 By: /s/ Moira Ong Name: Moira Ong Title: Chief Financial Officer 3